Translating Sovereign Science into
Platform-Grade Biotechnologies.
GenRey connects discovery biology, micro-fluidic bioengineering, computational omics, and sovereign deployment infrastructure to turn laboratory breakthroughs into population-scale clinical platforms.
A Dual-Hub Engine Bridging Discovery & Sovereign Scale
GenRey rejects the slow, traditional single-asset model. Our dual-hub architecture pairs American biotechnology translation with sovereign-scale regional deployment across the Middle East and beyond.
U.S. Innovation & Translation Engine
Anchored in Texas, this engine brings together elite physician-scientists, PhD biophysicists, and micro-fluidic engineers to drive foundational research, bioactive synthesis, and device prototyping.
- ✓ Over 25 active R&D candidate programs under discovery
- ✓ Micro-fluidic kinetic delivery device prototyping
- ✓ Rigorous U.S. preclinical validation & IP filings
Partner Deployment & Sovereign Infrastructure
Connecting American scientific innovation directly with sovereign strategic partners across the Kingdom of Saudi Arabia, the UAE, and Qatar to establish localized manufacturing and population-scale clinical delivery.
- ✓ Sovereign bio-manufacturing facility establishment
- ✓ Regional clinical trial acceleration & hospital integration
- ✓ IP co-ownership & workforce capability building
Six Core R&D Vector Fields
Select a vector below to explore how GenRey combines device engineering, biological synthesis, and computational intelligence.
Hair Regeneration & Scalp Bio-Rejuvenation
iREY™ combines a proprietary micro-fluidic delivery device with a high-potency bioactive serum ecosystem. Engineered to reverse follicle cellular senescence, optimize local microcirculation, and re-establish active growth signaling pathways.
- Micro-droplet kinetic delivery with zero epidermal damage
- Proprietary bioactive serum preserving protein stability
- Targeted follicle androgen pathway modulation
- Designed for rapid clinical & sovereign deployment
iREY™ Delivery Architecture & DAMI™ Intelligence Layer
GenRey bridges the gap between active molecular biological discovery and physical clinical application through integrated hardware micro-fluidics and machine learning omics.
Micro-Fluidic Kinetic Chamber
Ejects bioactive serum micro-droplets at precise kinetic velocities to bypass outer stratum corneum without thermal or mechanical skin disruption.
The DAMI™ AI platform constantly analyzes kinetic delivery data and tissue uptake telemetry, automatically tuning formulation viscosity and micro-fluidic pulse rates for maximum therapeutic efficacy.
From Bench to Sovereign Clinical Deployment
Every GenRey initiative follows a sequenced 3-stage translational lifecycle designed to mitigate biological risk while optimizing speed to market.
Discovery & IP Creation
Target identification, candidate synthesis, micro-fluidic hardware design, and comprehensive patent portfolio protection.
Clinical Validation & Trials
Multi-center human clinical trials, dosage optimization, delivery device refinement, and safety protocol standardization.
Sovereign Production & Distribution
Establishing regional bio-manufacturing plants, workforce technology transfer, and commercial health system integration.
Proprietary Intellectual Property & Co-Ownership
GenRey builds defensible, high-moat intellectual property across hardware, bioactive formulations, computational models, and sovereign transfer frameworks.
Micro-Fluidic Hardware
Patented kinetic micro-droplet chambers, delivery nozzle geometry, and closed-loop sterile cartridge mechanisms.
Bioactive Serum Formulations
Proprietary peptide complexes, growth factor stabilization matrices, and localized tissue retention compounds.
DAMI™ AI Biomarker Models
Multi-omics computational pipelines for rapid target discovery and patient-specific dosage optimization.
Sovereign Tech Transfer
Structured co-ownership frameworks granting regional partners domestic manufacturing rights and sovereign IP equity.
World-Class Clinical & Scientific Governance
GenRey's R&D engine is guided by leading physician-scientists, micro-fluidic hardware pioneers, and global healthcare system advisors.
Dr. Aaron Wolfson
Specializes in healthcare innovation, medical device integration, and micro-fluidic hardware delivery mechanisms for therapeutic protocols.
View Full Profile →
Dr. Asim Elahi
Bridges scientific discovery initiatives with healthcare system integration, clinical protocol design, and sovereign deployment.
View Full Profile →
Dr. Jerry Lorren Dominic
Advises on clinical trial design, therapeutic safety monitoring, and translational regulatory compliance across international markets.
View Full Profile →
Accelerate Sovereign Biotechnology in Your Region
We collaborate with sovereign wealth funds, ministry bodies, institutional healthcare providers, and research centers to deploy platform-grade biotech capabilities.